Lifestyle and Environment Environmental Exposures

Phthalate exposure and children's health

Braun JM, Sathyanarayana S, Hauser R

Published April 2013 Current Opinion in Pediatrics
DOI 10.1097/MOP.0b013e32835e1eb6 PMID 23429708 PMC PMC3747651

RRM Academy Synopsis

Some phthalates may increase children's risk of allergic disease

A 2013 review of epidemiological research reports that studies suggest childhood DEHP and BBzP exposure may increase risk of allergic disease. DEHP and BBzP are phthalates, chemicals that make vinyl plastics flexible. Studies of some phthalates in pregnancy report associations with child development and behavior. The pattern was inconsistent across phthalates and behaviors.

Key Findings

  • In a New York City cohort of 407 women-child pairs, higher BBzP metabolites in maternal urine during pregnancy were linked to 50% increased odds of eczema by 24 months of age.
  • In nested case-control studies of home dust in Bulgaria, Sweden and Taiwan, children in the top DEHP quartile had 1.4 to 2.7 times the likelihood of wheezing, asthma, rhinitis or allergy.
  • Among 244 New York City children aged 6 to 9, higher urinary DEP and BBzP metabolites were associated with 6.6 and 8.7% higher fractional exhaled nitric oxide, respectively.
  • Among 277 New York City mother-child pairs, children whose mothers had higher BBzP exposure had 1.3 to 1.4 times the risk of internalizing behaviors rated borderline or clinically significant.
  • Two studies of male infants reported shorter anogenital distance, a marker of fetal testosterone production, with higher maternal DEHP metabolites: 85 infants in the US and 111 in Japan.

Interpretation

This 2013 review brings together cohort, case-control and cross-sectional studies. The studies link phthalate exposure before birth and in childhood to allergic disease, behavior and reproductive development. The authors call the results associations. The authors note that future allergy studies should look at other causes of asthma in the environment. No proven way to lower phthalate exposure exists yet. The findings support larger studies of phthalate exposure and child health.

RRM Context

The authors call some phthalates suspected endocrine disrupting compounds. They note that US product rules do not lower exposure for women of child bearing age. Restorative reproductive medicine takes a cause-based view of reproductive health. That view includes environmental exposures for both partners.

Abstract

Purpose of Review

Phthalates are multifunctional chemicals used in personal care products, medications, and plastics. We reviewed the epidemiological literature examining the relationship between early life phthalate exposure and pediatric health outcomes.

Recent Findings

Five studies from Asia, Europe, and the United States suggest that childhood exposure to di-2-ethylhexyl phthalate (DEHP) and butylbenzyl phthalate (BBzP) may increase the risk of allergic diseases including asthma and eczema. Six studies from four different prospective cohorts report that gestational BBzP, DEHP, di-butyl phthalate (DBP), and di-ethyl phthalate (DEP) exposures are associated with alterations in infant/toddler physical development as well as parent-reported externalizing, internalizing, and autistic-like child behavior. However, there are inconsistencies related to the specific phthalates and behavioral domains. Two small studies report shorter anogenital distance among male infants with higher gestational phthalate exposure.

Summary

Several epidemiological studies suggest fetal and childhood exposure to some phthalates may perturb normal development, with several studies consistently reporting increased risk of allergic diseases with DEHP and BBzP exposure. Although anticipatory guidance is not evidence-based at this time, providers can counsel concerned patients to reduce phthalate exposures in order to protect the developing fetus and child from potential adverse health outcomes.

Topics

By this author

Related research

Lifestyle and Environment › Environmental Exposures › Endocrine Disrupting Chemicals
Joseph M Braun, Sheela Sathyanarayana, Russ Hauser
Joe Braun, Joey Braun, J Braun, S Sathyanarayana, R Hauser
PMID 23429708 23429708 DOI 10.1097/MOP.0b013e32835e1eb6 10.1097/MOP.0b013e32835e1eb6 Braun et al. 2013, Braun 2013